MedPath

Common thoughts occuring in insomnia and a comparison of psychological treatments

Completed
Conditions
Insomnia
Mental Health - Other mental health disorders
Registration Number
ACTRN12610000123044
Lead Sponsor
Australian National University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria

Native or primary English speaker

Insomnia Treatment Group (50 participants)
Subjective complaint of insomnia and meeting the Research Diagnostic Criteria (Amercian Academy of Sleep Medicine, 2004) as follows:
One or more sleep-related complaints (initiating, maintaining, early waking, poor quality)
Difficulty occurs despite adequate opportunity for sleep
At least one daytime impairment reported (e.g. fatigue, mood, attention, concentration, motivation, energy, worries about sleep)
In addition, the sleep difficulties occurring for a minimum of 3 -6 months

Participants will be accepted into the trial if they have comorbid depression or anxiety conditions that are assessed to be relatively stable, mild to moderate, and not requiring immediate treatment targeted at those symptoms.

Insomnia Thought Study (including Insomnia Treatment participants plus 50 normal sleepers)
Meet the Research Diagnostic Criteria for Normal Sleepers:
No complaints of sleep disturbance or daytime symptoms attributable to unsatisfactory sleep
Has a routine standard sleep/wake schedule
No evidence of a sleep-disruptive medical or mental disorder
No evidence of sleep disruption due to substance exposure, use, abuse, or withdrawal
No evidence of a primary sleep disorder

Exclusion Criteria

Under 18yrs and over 60yrs. Not native or primary English speakers Participation in existing psychological treatment programs that may confound the results of the present study (e.g. CBT programs). Sleep disturbance not meeting the Inclusion Criteria Evidence of severe psychiatric illness or primary sleep disorder other than insomnia. Sleep disruption due to substance exposure, use, abuse, or withdrawal.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mean score on Insomnia Severity Index[At baseline, post-group treatment (approxiamtely 2 weeks), post-CBT (approximately 6 weeks) and at one month follow-up.];Mean variables in sleep diary (e.g. time taken to sleep, wake after sleep onset, sleep duration and satisfaction)[At baseline, post-group treatment (approxiamtely 2 weeks), post-CBT (approximately 6 weeks) and at one month follow-up.];Mean Scores on Pittsburgh Sleep Quality Index[At baseline, post-group treatment (approxiamtely 2 weeks), post-CBT (approximately 6 weeks) and at one month follow-up.]
Secondary Outcome Measures
NameTimeMethod
Mean scores on Social Problem-Solving Inventory[At baseline, post-group treatment (approxiamtely 2 weeks), post-CBT (approximately 6 weeks) and at one month follow-up.];Mean scores on Dysfunctional Beliefs about Sleep Scale[At baseline, post-group treatment (approxiamtely 2 weeks), post-CBT (approximately 6 weeks) and at one month follow-up.];Mean scores on Depression, Anxiety and Stress index[At baseline, post-group treatment (approxiamtely 2 weeks), post-CBT (approximately 6 weeks) and at one month follow-up.];Mean scores on Penn State Worry Questionnaire[At baseline, post-group treatment (approxiamtely 2 weeks), post-CBT (approximately 6 weeks) and at one month follow-up.]
© Copyright 2025. All Rights Reserved by MedPath